3,101
Participants
Start Date
January 31, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
BufferGel
Participants will be given single-use, prefilled applicators of gel and will be instructed to apply one dose of BufferGel intravaginally up to 60 minutes before each vaginal intercourse while in the study.
PRO 2000/5 Gel
Participants will be given single-use, prefilled applicators of gel and will be instructed to apply one dose of PRO 2000/5 Gel intravaginally up to 60 minutes before each vaginal intercourse while in the study.
Placebo gel
Participants will be given single-use, prefilled applicators of gel and will be instructed to apply one dose of PRO 2000/5 Gel intravaginally up to 60 minutes before each vaginal intercourse while in the study.
Seke South CRS, Chitungwiza
Spilhaus CRS, Harare
3535 Market Street CRS, Philadelphia
University of North Carolina Lilongwe CRS, Lilongwe
College of Med. JHU CRS, Blantyre
Chatsworth CRS, Chatsworth
Med. Research Council-Hlabisa, Durban
Kamwala Clinic CRS, Lusaka
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
HIV Prevention Trials Network
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH